Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
CAR T in follicular lymphoma value and timing
Dr Lunning reviews strong CAR T efficacy in follicular lymphoma and the need for longer follow-up to assess durability.
Play episode from 28:35
Transcript
